Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation (Q36330594)

13 August 2017

Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation (English)

1 reference

13 August 2017

Johannes-Peter Stasch

4

object named as

Johannes-Peter Stasch

1 reference

13 August 2017

Oleg V Evgenov

1

1 reference

13 August 2017

Daniel S Kohane

2

1 reference

13 August 2017

Kenneth D Bloch

3

1 reference

13 August 2017

Gian P Volpato

5

1 reference

13 August 2017

Evangelia Bellas

6

1 reference

13 August 2017

Natalia V Evgenov

7

1 reference

13 August 2017

Emmanuel S Buys

8

1 reference

13 August 2017

Mark J Gnoth

9

1 reference

13 August 2017

Amanda R Graveline

10

1 reference

13 August 2017

Rong Liu

11

1 reference

13 August 2017

Dean R Hess

12

1 reference

13 August 2017

Robert Langer

13

1 reference

13 August 2017

Warren M Zapol

14

1 reference

13 August 2017

language of work or name

English

0 references

publication date

13 September 2007

1 reference

American Journal of Respiratory and Critical Care Medicine

13 August 2017

1 reference

13 August 2017

176

1 reference

13 August 2017

11

1 reference

13 August 2017

1138-1145

1 reference

Inhaling medicines: delivering drugs to the body through the lungs

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Update in pulmonary hypertension 2005.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Matrix effects during analysis of plasma samples by electrospray and atmospheric pressure chemical ionization mass spectrometry: practical approaches to their elimination

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Aerosolized vasodilators in pulmonary hypertension

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Inhalation delivery of proteins from ethanol suspensions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

NO-independent regulatory site on soluble guanylate cyclase

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Inhibition of phosphodiesterase 1 augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs with acute pulmonary hypertension

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Mechanisms underlying relaxation of rabbit aorta by BAY 41-2272, a nitric oxide-independent soluble guanylate cyclase activator.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Efficacy and optimal dose of sildenafil in primary pulmonary hypertension

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Recent advances in pulmonary drug delivery using large, porous inhaled particles

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

Pulmonary Arterial Hypertension

22 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1164%2FRCCM.200707-1121OC

Inhaled alternatives to nitric oxide

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176100

BAY 41-2272, a Direct Activator of Soluble Guanylate Cyclase, Reduces Right Ventricular Hypertrophy and Prevents Pulmonary Vascular Remodeling during Chronic Hypoxia in Neonatal Rats

21 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1164%2FRCCM.200707-1121OC

Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17872487

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Inhaled nitric oxide for the adult respiratory distress syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17872487

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Formulation and physical characterization of large porous particles for inhalation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17872487

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1164/RCCM.200707-1121OC

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

17872487

1 reference